FETOPLACENTAL ANGIOGENESIS DURING NORMAL PREGNANCY: A ROLE OF PLACENTAL GROWTH FACTOR AND ANGIOPOIETINS


Cite item

Full Text

Abstract

The paper gives the data available in the literature on a role of placental growth factor and angiopoietins in fetoplacental angiogenesis. Emphasis is laid on the implication of angiopoietin receptors in the formation of placental vasculature and accordingly in the normal development of pregnancy.

About the authors

K A PAVLOV

E A DUBOVA

A I ShchEGOLEV

K A Pavlov

Academician V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health and Social Development of the Russian Federation, Moscow

Academician V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health and Social Development of the Russian Federation, Moscow

Ye A Dubova

Academician V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health and Social Development of the Russian Federation, Moscow

Academician V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health and Social Development of the Russian Federation, Moscow

A I Shchegolev

Academician V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health and Social Development of the Russian Federation, Moscow

Academician V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health and Social Development of the Russian Federation, Moscow

References

  1. Соколян А.В., Мурашко А.В., Кречетова Л.В. и др. Динамика ангиогенных факторов роста во время беременности и в послеродовом периоде у беременных с хронической венозной недостаточностью //Акуш. и гин. - 2009. - № 2. - С. 20-23.
  2. Тютюнник В.Л., Бурлев В.А., Зайдиева З.С. Морфофункциональное состояние системы мать-плацента-плод при плацентарной недостаточности и инфекции // Акуш. и гин. - 2003. - № 6. - С. 11-16.
  3. Achen M.G., Gad J.M., Stacker S.A. et al. Placenta growth factor and vascular endothelial growth factor are coexpressed during early embryonic development // Growth Factors. - 1997. - Vol. 15. - P. 69-80.
  4. Albrecht E.D., Babischkin J.S., Pepe G.J. Regulation of placental villous angiopoietin-1 and -2 expression by estrogen during baboon pregnancy // Mol. Reprod. Dev. - 2008. - Vol. 75. - P. 504-511.
  5. Ali K.Z., Burton G.J., KhalidM.E. et al. Concentrations of free vascular endothelial growth factor in the maternal and foetal circulations during pregnancy: A cross-sectional study // J. Mater. Fet. Neonat. Med. - online on 04 Jan 2010.
  6. Babischkin J.S., Suresch D.L., Pepe G.J. et al. Differential expression of placental villous angiopoietin-1 and -2 during early, mid and late baboon pregnancy // Placenta. - 2007. - Vol. 28. - P. 212-218.
  7. Brown K.J., Maynes S.F., Bezos A. et al. A novel in vitro assay for human angiogenesis // Lab. Invest. - 1996. - Vol. 75. - P. 539-555.
  8. Cao Y., Chen H., Zhou L. et al. Heterodimers of placenta growth factor/vascular endothelial growth factor. Endothelial activity, tumor cell expression, and high affinity binding to Flk-1/KDR // J. Biol. Chem. - 1996. - Vol. 271. - P. 3154-3162.
  9. Cao Y., Ji W.R., Qi P. et al. Placenta growth factor: identification and characterization of a novel isoform generated by mRNA alternative splicing // Biochem. Biophys. Res. Commun. - 1997. - Vol. 235. - P. 493-498.
  10. Carmeliet P., Moons L., Luttun A. et al. Synergism between vascular endothelial growth factor and placenta growth factor contributes to angiogenesis and plasma extravasation in pathological conditions // Nat. Med. - 2001. - Vol. 7. - P. 575-583.
  11. Charnock-Jones D.S. Soluble flt and the angiopoietins in the development and regulation of placental vasculature // J. Anat. - 2002. - Vol. 200. - P. 607-615.
  12. Charnock-Jones D.S., Clark D.E., Licence D. et al. Distribution of vascular endothelial growth factor (VEGF) and its binding sites at the maternal-fetal interface during gestation in pigs // Reproduction. - 2001. - Vol. 122. - P. 753-760.
  13. Clark D.E., Smith S.K., He Y. et al. A vascular endothelial growth factor antagonist is produced by the human placenta and released into the maternal circulation // Biol. Reprod. - 1998. - Vol. 59. - P. 1540-1548.
  14. Clark D.E., Smith S.K., Sharkey A.M., Charnock- Jones D.S. Localization of VEGF and expression of its receptors flt and KDR in human placenta throughout pregnancy // Hum. Reprod. - 1996. - Vol. 11. - P. 1090-1098.
  15. Crescimanno C., Marzioni D., Persico M.G. et al. Expression of bFGF, PlGF and their receptors in the human placenta // Placenta. - 1995. - Vol. 16. - P. A.13.
  16. Davis S., Aldrich T.H., Jones P.F. et al. Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning // Dev. Cell. - 1996. - Vol. 87. - P. 1161-1169.
  17. Demir R., Kaufmann P., Erbengi T. Ultrastructural observations on angiogenetic cells formation and differentiation toward vascular endothelium in human placental villi. In: Catravas JD, Callow AD, Ryan US, editors. Vascular endothelium: physiological basis of clinical problems I. - New York-London: Plenum Press, 1992. - P. 240-242.
  18. Demir R., Kayisli U.A., Seval Y. et al. Sequential expression of VEGF and its receptors in human placental villi during very early pregnancy: differences between placental vasculogenesis and angiogenesis // Placenta. - 2004. - Vol. 25. - P. 560-572.
  19. Dunk C., Shams M., Nijjar S. et al. Angiopoietin-1 and angiopoietin-2 activate trophoblast Tie-2 to promote growth and migration during placental development // Amer. J. Pathol. - 2000. - Vol. 156. - P. 2185-2199.
  20. Eklund L., Olsen B.R. Tie receptors and their angiopoietin ligands are context-dependent regulators of vascular remodeling // Exp. Cell. Res. - 2006. - Vol. 312. - P. 630-641.
  21. Gale N.W., Thurston G., Hackett S.F. et al. Angiopoietin-2 is required for postnatal angiogenesis and lymphatic patterning, and only the latter role is rescued by Angiopoietin-1 // Dev. Cell. - 2002. - Vol. 3. - P. 411-423.
  22. Geva E., Ginzinger D.G., Zaloudek C.J. et al. Human placental vascular development: vasculogenic and angiogenic (branching and nonbranching) transformation is regulated by vascular endothelial growth factor-A, angiopoietin-1, and angiopoietin-2 // J. Clin. Endocrinol. Metab. - 2002. - Vol. 87. - P. 4213-4224.
  23. Ghosh D., Sharkey A.M., Charnock-Jones D.S. et al. Expression of vascular endothelial growth factor (VEGF) and placental growth factor (PlGF) in conceptus and endometrium during implantation in the rhesus monkey // Mol. Hum. Reprod. - 2000. - Vol. 6. - P. 935-941.
  24. Goldman-Wohl D.S., Ariel I., Greenfield C. et al. Tie-2 and angiopoietin-2 expression at the fetale maternal interface: a receptor ligand model for vascular remodelling // Mol. Hum. Reprod. - 2000. - Vol. 6. - P. 81-87.
  25. Huang X.L., Takakura N., Suda T. In vitro effects of angiopoietins and VEGF on hematopoietic and endothelial cells // Biochem. Biophys. Res. Commun. - 1999. - Vol. 264. - P. 133-138.
  26. Kayisli U. A., Cayli S., Seval Y. et al. Spatial and temporal distribution of Tie-1 and Tie-2 during very early development of the human placenta // Placenta. - 2006. - Vol. 27. - P. 648-659.
  27. Khaliq A., Dunk C., Jiang J. et al. Hypoxia down-regulates placenta growth factor, whereas fetal growth restriction up-regulates placenta growth factor expression: molecular evidence for "placental hyperoxia" in intrauterine growth restriction // Lab. Invest. - 1999. - Vol. 79. - P. 151-170.
  28. Khaliq A., Li X.F., Shams M. et al. Localization of placenta growth factor (PlGF) in human term placenta // Growth Factors. - 1996. - Vol. 13. - P. 243-250.
  29. Korhonen J., Partanen J., Armstrong E. et al. Enhanced expression of the tie receptor tyrosine kinase in endothelial cells during neovascularization // Blood. - 1992. - Vol. 80. - P. 2548-2555.
  30. Kumazaki K., Nakayama M., Suehara N., Wada Y. Expression of vascular endothelial growth factor, placental growth factor, and their receptors Flt-1 and KDR in human placenta under pathologic conditions // Hum. Pathol. - 2002. - Vol. 33. - P. 1069-1077.
  31. Lang I., Pabst M.A., Hiden U. et al. Heterogeneity of microvascular endothelial cells isolated from human term placenta and macrovascular umbilical vein endothelial cells // Eur. J. Cell. Biol. - 2003. - Vol. 82. - P. 163-173.
  32. Lijnen H.R., Christiaens V., Scroyen I. et al. Impaired adipose tissue development in mice with inactivation of placental growth factor function // Diabetes. - 2006. - Vol. 5. - P. 2698-2704.
  33. LuttunA., TjwaM., MoonsL. et al. Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1 // Nat. Med. - 2002. - Vol. 8. - P. 831-840.
  34. Maglione D., Guerriero V., Viglietto G. et al. Isolation of human placenta cDNA coding for a protein related to the vascular permeability factor // Proc. Natl. Acad. Sci. USA. - 1991. - Vol. 88. - P. 9267-9271.
  35. Maglione D., Guerriero V., Viglietto G. et al. Two alternative mRNAs coding for the angiogenic factor, placenta growth factor (PlGF), are transcribed from a single gene of chromosome 14 // Oncogene. - 1993. - Vol. 8. - P. 925- 931.
  36. Maisonpierre P.C., Suri C., Jones P.F. et al. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis // Science. - 1997. - Vol. 277. - P. 55-60.
  37. Miao H.Q., Soker S., Feiner L. et al. Neuropilin-1 mediates collapsin-1/ semaphorin III inhibition of endothelial cell motility: functional competion of collapsin-1 and vascular endothelial growth factor-165 // J. Cell. Biol. - 1999. - Vol. 146. - P. 233-242.
  38. MigdalM., Huppertz B., Tessler S. et al. Neuropilin-1 is a placenta growth factor-2 receptor // J. Biol. Chem. - 1998. - Vol. 273. - P. 22272- 22278.
  39. Odorisio T., Schietroma C., Zaccaria M.L. et al. Mice overexpressing placenta growth factor exhibit increased vascularization and vessel permeability // J. Cell. Sci. - 2002. - Vol. 115. - P. 2559-2567.
  40. Partanen J., Dumont D. Functions of Tie1 and Tie2 receptor tyrosine kinases in vascular development. - Berlin: Springer-Verlag, 1999.
  41. Persico M.G., Vincenti V., Di Palma T. Structure, expression and receptor-binding properties of placenta growth factor (PlGF) // Curr. Top. Microbiol. Immunol. - 1999. - Vol. 237. - P. 31-40.
  42. Ribatti D. The discovery of the placental growth factor and its role in angiogenesis: a historical review // Angiogenesis. - 2008. - Vol. 11. - P. 215-221.
  43. Sato T.N., Tozawa Y., Deutsch U. et al. Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation // Nature. - 1995. - Vol. 376. - P. 70-74.
  44. Seval Y., Korgun E.T., Demir R. Hofbauer cells in early human placenta: possible implications in vasculogenesis and angiogenesis // Placenta. - 2007. - Vol. 28. - P. 841-845.
  45. Seval Y., Sati L., Celik-Ozenci C. et al. The distribution of angiopoietin-1, angiopoietin-2 and their receptors tie-1 and tie-2 in the very early human placenta // Placenta. - 2008. - Vol. 29. - P. 809-815.
  46. Shiraishi S., Nakagawa K., Kinukawa N. et al. Immunohistochemical localization of vascular endothelial growth factor in the human placenta // Placenta. - 1996. - Vol. 17. - P. 111- 121.
  47. Shore V.H., Wang T-H., Wang C-L. et al. Vascular endothelial growth factor, placenta growth factor and their receptors in isolated human trophoblast // Placenta. - 1997. - Vol. 18. - P. 657-665.
  48. Suri C., McClain J., Thurston G. et al. Increased vascularization in mice overexpressing angiopoietin-1 // Science. - 1998. - Vol. 282. - P. 468-471.
  49. Visconti R.P., Richardson C.D., Sato T.N. Orchestration of angiogenesis and arteriovenous contribution by angiopoietins and vascular endothelial growth factor (VEGF) // Proc. Natl. Acad. Sci. USA. - 2002. - Vol. 99. - P. 8219-8224.
  50. Voros G., Maquoi E., Demeuelemeester D. et al. Modulation of angiogenesis during adipose tissue development in murine models of obesity // Endocrinology. - 2005. - Vol. 146. - P. 4545-4554.
  51. Vuckovic M., Ponting J., Terman B.I. et al. Expression of the vascular endothelial growthfactor receptor, KDR, in human placenta // J. Anat. - 1996. - Vol. 188. - P. 361-366.
  52. Vuorela P., Carpen O., Tulppala M. et al. VEGF, its receptors and the tie receptors in recurrent miscarriage // Mol. Hum. Reprod. - 2000. - Vol. 6. - P. 276-282.
  53. Vuorela P., Hatva E., Lymboussaki A. et al. Expression of vascular endothelial growth factor and placenta growth factor in human placenta // Biol. Reprod. - 1997. - Vol. 56. - P. 489- 494.
  54. Ward N.L., Dumont D.J. The angiopoietins and Tie2/Tek: adding to the complexity of cardiovascular development // Semin. Cell Dev. Biol. - 2002. - Vol. 13. - P. 19-27.
  55. Witzenbichler B., Maisonpierre P.C., Jones P. et al. Chemotactic properties of angiopoietin-1 and -2, ligands for the endothelial-specific receptor tyrosine kinase Tie2 // J. Biol. Chem. - 1998. - Vol. 273. - P. 18514-18521.
  56. Wulff C., Wilson H., Dickson S.E. et al. Hemochorial placentation in the primate: expression of vascular endothelial growth factor, angiopoietins, and their receptors throughout pregnancy // Biol. Reprod. - 2002. - Vol. 66. - P. 802-812.
  57. Yang W., Ahm H., Hinrichs M. et al. Evidence of a novel isoform of placenta growth factor (PlGF-4) expressed in human throphoblast and endothelial cells // J. Reprod. Immunol. - 2003. - Vol. 60. - P. 53-60.
  58. Yuan H.T., Venkatesha S., Chan B. et al. Activation of the orphan endothelial receptor Tie1 modifies Tie2-mediated intracellular signaling and cell survival // Faseb. J. - 2007. - Vol. 21. - P. 3171-3183.
  59. Ziche M., Maglione D., Ribatti D. et al. Placenta growth factor-1 is chemotactic, mitogenic, and angiogenic // Lab. Invest. - 1997. - Vol. 76. - P. 517-531.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies